Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol (Q25255803)

6 July 2017

title

Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol (English)

1 reference

6 July 2017

0 references

0 references

budesonide/formoterol

1 reference

E D Bateman

1

1 reference

6 July 2017

L Fairall

series ordinal

2

1 reference

6 July 2017

D M Lombardi

series ordinal

3

1 reference

6 July 2017

R English

series ordinal

4

1 reference

6 July 2017

language of work or name

English

0 references

publication date

24 January 2006

1 reference

6 July 2017

1 reference

6 July 2017

volume

7

1 reference

6 July 2017

issue

1

0 references

page(s)

13

1 reference

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386666

Inflammatory events in severe acute asthma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386666

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386666

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386666

Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386666

Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386666

Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386666

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386666

A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386666

Inhaled flunisolide for acute severe asthma

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386666

Acute resistant asthma caused by excessive beta-2-adrenoceptor agonist inhalation and reversed by inhalation of beclomethasone

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386666

Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-13

Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-13

Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-13

Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-13

Single-dose inhaled budesonide in subjects with chronic asthma

21 January 2018

1 reference

12 December 2020

Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma

1 reference

12 December 2020

Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients

1 reference

12 December 2020

Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency

1 reference

12 December 2020

Onset and duration of action of single doses of formoterol inhaled via Turbuhaler

1 reference

12 December 2020

Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group

1 reference

12 December 2020

Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI

1 reference

12 December 2020

British guideline on the management of asthma

1 reference

12 December 2020

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-7-13

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference

6 July 2017

1 reference